Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nikita Levchenko"'
Autor:
Stepan Ergnyan, Nikolai Krotov, Viktoriya Shabinskaya, Roman Yurin, Nikita Levchenko, Evgeny Levchenko, Vitalii Shutov, Azat Murtazin
Publikováno v:
Problems in oncology. 67:59-63
This article summarizes our own experience of reconstructive operations with resection and plastic repair of the superior vena cava in the field of locally advanced lung cancer surgery. Both technical aspects and methodological approaches of this typ
Autor:
Nina Karaseva, Vladimir M. Moiseyenko, Ivan S. Sardaryan, Maxim M. Kholmatov, Svetlana V. Odintsova, Nikita M. Volkov, Elena A. Filippova, Natalia V. Mitiushkina, Alexandra M. Lozhkina, Fedor V. Moiseyenko, Vladislav I. Tiurin, Sergey Orlov, Nikita Levchenko, Evgeny N. Imyanitov, Aglaya G. Iyevleva
Publikováno v:
Biochimie. 154:19-24
Multiple laboratory evidences indicate that distinct variants of ALK translocations differ in their biochemical properties and responsiveness to ALK tyrosine kinase inhibitors (TKIs). These data are supported by some clinical studies, which showed im
Autor:
Natalya Mityushkina, Yevgeniy Imyanitov, Yevgeniy Levchenko, Fedor Moiseenko, Nikita Levchenko, Vladislav Tyurin, Aglaya Ievleva
Publikováno v:
Problems in oncology. 64:331-334
A patient with lung cancer carrying ROS1 translocation was treated by crizotinib and then subjected to surgery. Morphological analysis revealed pathologic complete response in surgically removed tissues, while PCR test provided convincing evidence fo
Autor:
Boris Kasparov, Evgeny Levchenko, Margarita Zernova, Ponomarenko Gennady, Adhamov Bahtyar, Khidishyan Karina, Nikita Levchenko, Valeriya Kluge, Roman Donskih, Kristina Kondrateva, Alexey Belyaev, Tatiana Semiglazova, Anton Krutov, Vladislav Semiglazov, Evgeniya Vladimirovna Kharchenko, Kovlen Denis
Publikováno v:
Journal of Clinical Oncology. 37:e23189-e23189
e23189 Key words: physical therapy, rehabilitation, lung cancer. Background: The strategy of searching evidences for using rehabilitation technologies in patients with lung cancer (LC) is based on scientometric analysis. Methods: Since 1991 to 2018 a
Autor:
Svetlana N. Aleksakhina, Nikita M. Volkov, Fedor Moiseenko, Alexander Ivantsov, Ksenia Shelekhova, Albina Gabina, Vladimir Moiseyenko, Alexander Myslik, Kirill K. Kryukov, Elizaveta Artem'eva, Nikita Levchenko
Publikováno v:
Web of Science
e21528 Background: Despite impressive clinical efficacy in response rate, increase in PFS and sometimes in OS EGFR TKI rarely cure cancer patients, as all of them inevitably develop resistance. Small fractions of residual cells appear to be a reservo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a442934a616778da73c04b95582ec593
https://publons.com/wos-op/publon/46596006/
https://publons.com/wos-op/publon/46596006/